Implementing the end TB strategy and the intersection with the sustainable development goals, 2016-2030

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 110, Issue 3, 2015, Pages 145-147

  Fitchett, Joseph R ^a   MacPherson, Peter ^b,c   Corbett, Elizabeth L ^d,e  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

End TB Strategy; Sustainable Development Goals; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; EDITORIAL; GOAL ATTAINMENT; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; MOTIVATION; SUSTAINABLE DEVELOPMENT; TUBERCULOSIS; WORLD HEALTH ORGANIZATION; DEVELOPING COUNTRY; DISEASE ERADICATION; GLOBAL HEALTH; TUBERCULOSIS, PULMONARY;

DEVELOPING COUNTRIES; DISEASE ERADICATION; GLOBAL HEALTH; GOALS; HUMANS; TUBERCULOSIS, PULMONARY;

EID: 84959919454     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trw010     Document Type: Editorial

References (28)

1. United Nations. The Sustainable Development Goals 2015. New York:United Nations. https://sustainabledevelopment.un.org/ [accessed 9 January 2016].
2. Sachs JD. From Millennium Development Goals to Sustainable Development Goals. Lancet 2012;379:2206-11.
3. Dora C, Haines A, Balbus J et al. Indicators linking health and sustainability post-2015 development agenda. Lancet 2014;385:380-91.
4. United Nations. The Millennium Development Goals Report 2015. New York: United Nations. http://www.un.org/millenniumgoals/ reports.shtml [accessed 9 January 2016].
5. Schäferhoff M, Fewer S, Kraus J et al. Lancet 2015;386:2436-41.
6. WHO. Health in all policies: framework for country action. Geneva:World Health Organization; 2014. http://www.who.int/healthpromotion/ frameworkforcountryaction/en/ [accessed 9 January 2016].
7. Becerra-Posada F. Health in all policies: a strategy to support the Sustainable Development Goals. Lancet Glob Health 2015;3:e360.
8. WHO. Global tuberculosis report 2015. Geneva: World Health Organization; 2015. http://www.who.int/tb/publications/global_ report/en/ [accessed 9 January 2016].
9. Hargreaves JR, Boccia D, Evans CA et al. The social determinants of tuberculosis: from evidence to action. Am J Public Health 2011;101:654-62.
10. Fitchett JR. Antibiotics, copayments, and antimicrobial resistance:investment matters. Lancet Infect Dis 2015;15:1125-7.
11. Fitchett JR, Atun R. Antimicrobial resistance: opportunity for Europe to establish global leadership. Lancet Infect Dis 2015;pii:S1473-3099(15)00410-7.
12. WHO. End TB Strategy 2015. Geneva: World Health Organization; 2015. http://www.who.int/tb/post2015_strategy/en/ [accessed 9 January 2016].
13. UplekarM,Weil D, Lonnroth K et al. WHO's new End TB Strategy. Lancet 2015;385:1799-801.
14. Lönnroth K, Raviglione M. The WHO's new End TB Strategy in the post-2015 era: working with the Sustainable Development Goals Trans R Soc Trop Med Hyg 2016;110:148-50.
15. Prasad A, Ross A, Rosenberg P, Dye C. A world of cities and the end of TB. Trans R Soc Trop Med Hyg 2016;110:151-2.
16. Kunii O, Yassin MA,Wandwalo E. Investing to end epidemics: the role of the Global Fund to control TB by 2030. Trans R Soc Trop Med Hyg 2016;110:153-4.
17. Seddon JA, Graham SM. Childhood TB: can the End TB Strategy deliver? Trans R Soc Trop Med Hyg 2016;110:155-7.
18. Wieczorek Torrens A, Rasella D, Boccia D. Effectiveness of a conditional cash transfer program on TB cure rate: a retrospective cohort study in Brazil. Trans R Soc Trop Med Hyg 2016;110:199-206.
19. Pai M, Daftary A, Satyanarayana S. TB control: challenges and opportunities for India. Trans R Soc Trop Med Hyg 2016;110:158-60.
20. Huynh G. Can China achieve the WHO global targets for TB control by 2035? Trans R Soc Trop Med Hyg 2016;110:161-62.
21. McDowell A, PaiM. Alternative medicine: an ethnographic study of how practitioners of Indian medical systems manage TB in Mumbai. Trans R Soc Trop Med Hyg 2016;110:192-8.
22. Sloan DJ, Lewis JM. Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings. Trans R Soc Trop Med Hyg 2016;110:163-72.
23. Harries AD, Kumar AMV, Satyanarayana S. Addressing diabetes mellitus as part of the strategy for ending TB. Trans R Soc Trop Med Hyg 2016;110:173-9.
24. Lawn SD, Gupta-Wright A. Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications. Trans R Soc Trop Med Hyg 2016;110:180-5.
25. Manjelievskaia J, Erck D, Piracha S. Drug-resistant TB: deadly, costly and in need of a vaccine. Trans R Soc Trop Med Hyg 2016;110:186-91.
26. Kalra A. Global fight against tuberculosis hinges on India stepping up funding: WHO. November 19 2015. Reuters. http://www.reuters.com/ article/us-india-health-tb-idUSKCN0T810N20151119 [accessed 9 January 2016].
27. Davis A, Matthews Z, Szabo S, Fogstad H. Measuring the SDGs: a two-track solution. Lancet 2015;386:221-2.
28. Schmidt H, Gostin LO, Emanuel EJ. Public health, universal health coverage, and Sustainable Development Goals: can they coexist? Lancet 2015;386:928-30.